JUNS
Jupiter Neurosciences Inc.

407
Mkt Cap
$21M
Volume
70,784.00
52W High
$3.33
52W Low
$0.48
PE Ratio
-2.68
JUNS Fundamentals
Price
$0.5811
Prev Close
$0.61
Open
$0.571
50D MA
$0.9482
Beta
0.11
Avg. Volume
686,450.70
EPS (Annual)
-$0.0737
P/B
365.27
Rev/Employee
$0.00
$350.66
Loading...
Loading...
Jupiter Neurosciences, Inc. is a clinical-stage pharmaceutical company engaged in treating neuroinflammation with a current focus on CNS disorders and rare diseases. The firm offers JOTROL, an enhanced orally administered resveratrol formulation, designed to deliver therapeutically relevant, safe levels of resveratrol. The company was founded by Christer Rosén, Alexander Rosén, Claes Wahlestedt, Marshall Hayward, and Shaun P. Brothers in January 2016 and is headquartered in Jupiter, FL.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
4

Frequently Asked Questions

What is Market Cap of Jupiter Neurosciences Inc?
What is the 52-week high for Jupiter Neurosciences Inc?
What is the 52-week low for Jupiter Neurosciences Inc?
What is Jupiter Neurosciences Inc stock price today?
What was Jupiter Neurosciences Inc stock price yesterday?
What is the PE ratio of Jupiter Neurosciences Inc?
What is the Price-to-Book ratio of Jupiter Neurosciences Inc?
What is the 50-day moving average of Jupiter Neurosciences Inc?
How many employees does Jupiter Neurosciences Inc have?

Latest JUNS News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.